Skip To Main Content
Wanying Qin on Muck Rack

Wanying Qin

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Wanying

Contact Wanying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

|
By Wanying Qin, Yuchen Zhou, Jiajie Tang, Yizhe Liu, Yi Zhu, Xudong Fei, Renfang Shi, Liya Suo, Weijia Liao
| Frontiers
Abstract Background: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death in China, characterized by insidious onset and poor prognosis. Most patients are diagnosed at intermediate-advanced stages with unresectable HCC (uHCC), and the combination of transarterial chemoembolization (TACE) with targeted and immunotherapy has shown promising efficacy.
Open in Who Shared Issue with article?
See all 1 articles